3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
7
NIH
3
NETWORK
2
INDUSTRY
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Uveal Melanoma
3
Melanoma
3
Neoplasms
1
Multiple Myeloma
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Interventions
Drug Therapy
4
pembrolizumab
3
Thermography
2
Surveys and Questionnaires
2
Standard of Care
2
Quality of Life
2
Preoperative Exercise
2
Nivolumab
2
Moxibustion
2
Hematologic Tests
2
Cyclophosphamide
2
Chemoradiotherapy
2
vandetanib
1
sinovac COVID-19 vaccine
1
lenvatinib
1
ibrutinib
1
fludarabine
1
encorafenib
1
durvalumab
1
binimetinib
1
beta Carotene
1
avelumab
1
atezolizumab
1
Zoledronic Acid
1
Zinc
1
Vitamin E
1
Vascular Access Devices
1
Validation Studies as Topic
1
Urination
1
Ultraviolet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Neoplasms
×
Melphalan
×
Clear all
NCT05477589
2024-12-19
SCRIPT-AML
Vastra Gotaland Region
Phase 3
Recruiting
170 enrolled